339 related articles for article (PubMed ID: 37917650)
1. The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake.
Moradpour J; Shajarizadeh A; Carter J; Chit A; Grootendorst P
PLoS One; 2023; 18(11):e0293184. PubMed ID: 37917650
[TBL] [Abstract][Full Text] [Related]
2. Global state of education-related inequality in COVID-19 vaccine coverage, structural barriers, vaccine hesitancy, and vaccine refusal: findings from the Global COVID-19 Trends and Impact Survey.
Bergen N; Kirkby K; Fuertes CV; Schlotheuber A; Menning L; Mac Feely S; O'Brien K; Hosseinpoor AR
Lancet Glob Health; 2023 Feb; 11(2):e207-e217. PubMed ID: 36565702
[TBL] [Abstract][Full Text] [Related]
3. Children's rates of COVID-19 vaccination as reported by parents, vaccine hesitancy, and determinants of COVID-19 vaccine uptake among children: a multi-country study from the Eastern Mediterranean Region.
Khatatbeh M; Albalas S; Khatatbeh H; Momani W; Melhem O; Al Omari O; Tarhini Z; A'aqoulah A; Al-Jubouri M; Nashwan AJ; Adwan G; Altaany Z; Nashwan A; Al-Waqfi K; Abuirsheid L; Ayasreh R; Al Mutairi M; Al-Tammemi AB
BMC Public Health; 2022 Jul; 22(1):1375. PubMed ID: 35850675
[TBL] [Abstract][Full Text] [Related]
4. The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries.
Duroseau B; Kipshidze N; Limaye RJ
Front Public Health; 2022; 10():1087138. PubMed ID: 36711400
[TBL] [Abstract][Full Text] [Related]
5. Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.
Bor J; Assoumou SA; Lane K; Diaz Y; Ojikutu BO; Raifman J; Levy JI
PLoS Med; 2023 Jan; 20(1):e1004167. PubMed ID: 36719864
[TBL] [Abstract][Full Text] [Related]
6. Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.
Strupat C; Shigute Z; Bedi AS; Rieger M
PLoS One; 2022; 17(3):e0264633. PubMed ID: 35239711
[TBL] [Abstract][Full Text] [Related]
7. Vaccine hesitancy among healthcare workers in low- and middle-income countries during the COVID-19 pandemic: Results from facility surveys across six countries.
Baral P; Ahmed T; Amor Fernandez P; Peters MA; Drouard SHP; Muhoza P; Mwinnyaa G; Mwansambo C; Nzelu C; Tassembedo M; Uddin MH; Wesseh CS; Yansane ML; Bergeron JR; Karibwami AD; Lopez Chicheri TIOZ; Ogunlayi MIA; Sieleunou I; Hashemi T; Hansen PM; Shapira G
PLoS One; 2023; 18(7):e0288124. PubMed ID: 37418435
[TBL] [Abstract][Full Text] [Related]
8. Effects of side-effect risk framing strategies on COVID-19 vaccine intentions: a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Elife; 2022 Aug; 11():. PubMed ID: 35971757
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions.
Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I
Front Public Health; 2021; 9():709127. PubMed ID: 34422750
[TBL] [Abstract][Full Text] [Related]
10. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK.
Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S
Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642
[TBL] [Abstract][Full Text] [Related]
11. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
12. Sociodemographic predictors of and main reasons for COVID-19 vaccine hesitancy in eastern Oslo: a cross-sectional study.
Steinmetz L
BMC Public Health; 2022 Oct; 22(1):1878. PubMed ID: 36207702
[TBL] [Abstract][Full Text] [Related]
13. Assessing Inequities in COVID-19 Vaccine Roll-Out Strategy Programs: A Cross-Country Study Using a Machine Learning Approach.
Kazemi M; Bragazzi NL; Kong JD
Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214653
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
[TBL] [Abstract][Full Text] [Related]
15. Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries.
Marzo RR; Ahmad A; Islam MS; Essar MY; Heidler P; King I; Thiyagarajan A; Jermsittiparsert K; Songwathana K; Younus DA; El-Abasiri RA; Bicer BK; Pham NT; Respati T; Fitriyana S; Faller EM; Baldonado AM; Billah MA; Aung Y; Hassan SM; Asad MM; El-Fass KA; Bhattacharya S; Shrestha S; Hamza NAE; Friedmann P; Head M; Lin Y; Yi S
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010103. PubMed ID: 35089917
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
[TBL] [Abstract][Full Text] [Related]
17. Digital health literacy for COVID-19 vaccination and intention to be immunized: A cross sectional multi-country study among the general adult population.
Marzo RR; Su TT; Ismail R; Htay MNN; Essar MY; Chauhan S; Patalinghug ME; Kucuk Bicer B; Respati T; Fitriyana S; Baniissa W; Lotfizadeh M; Rahman F; Salim ZR; Villela EFM; Jermsittiparsert K; Aung Y; Hamza NAE; Heidler P; Head MG; Brackstone K; Lin Y
Front Public Health; 2022; 10():998234. PubMed ID: 36187686
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries.
Leigh JP; Moss SJ; White TM; Picchio CA; Rabin KH; Ratzan SC; Wyka K; El-Mohandes A; Lazarus JV
Vaccine; 2022 Jul; 40(31):4081-4089. PubMed ID: 35654620
[TBL] [Abstract][Full Text] [Related]
19. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study.
Chen Z; Zheng W; Wu Q; Chen X; Peng C; Tian Y; Sun R; Dong J; Wang M; Zhou X; Zhao Z; Zhong G; Yan X; Liu N; Hao F; Zhao S; Zhuang T; Yang J; Azman AS; Yu H
BMC Med; 2022 Apr; 20(1):130. PubMed ID: 35369871
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey.
Zheng W; Sun Y; Li H; Zhao H; Zhan Y; Gao Y; Hu Y; Li P; Lin YF; Chen H; Meng H; Yang C; Fang Q; Yuan J; Jiang Y; Liu S; Cai Y; Zou H
Hum Vaccin Immunother; 2021 Dec; 17(12):4971-4981. PubMed ID: 34890297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
